Medigene AG Statistics
Total Valuation
Medigene AG has a market cap or net worth of 2.24 million. The enterprise value is -10.84 million.
Market Cap | 2.24M |
Enterprise Value | -10.84M |
Important Dates
The next estimated earnings date is Friday, August 15, 2025.
Earnings Date | Aug 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +2.65% |
Shares Change (QoQ) | +5.09% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 14.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.28 |
PB Ratio | 0.11 |
P/TBV Ratio | 0.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.64 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 0.68 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.13.
Current Ratio | 2.39 |
Quick Ratio | 2.22 |
Debt / Equity | 0.13 |
Debt / EBITDA | n/a |
Debt / FCF | -0.17 |
Interest Coverage | -28.34 |
Financial Efficiency
Return on equity (ROE) is -63.93% and return on invested capital (ROIC) is -34.49%.
Return on Equity (ROE) | -63.93% |
Return on Assets (ROA) | -27.15% |
Return on Invested Capital (ROIC) | -34.49% |
Return on Capital Employed (ROCE) | -69.20% |
Revenue Per Employee | 91,703 |
Profits Per Employee | -196,226 |
Employee Count | 76 |
Asset Turnover | 0.21 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.58% in the last 52 weeks. The beta is 0.91, so Medigene AG's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +6.58% |
50-Day Moving Average | 2.23 |
200-Day Moving Average | 1.63 |
Relative Strength Index (RSI) | 100.00 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medigene AG had revenue of 7.98 million and -17.07 million in losses. Loss per share was -1.35.
Revenue | 7.98M |
Gross Profit | 6.38M |
Operating Income | -16.52M |
Pretax Income | -16.74M |
Net Income | -17.07M |
EBITDA | -15.84M |
EBIT | -16.52M |
Loss Per Share | -1.35 |
Balance Sheet
The company has 15.03 million in cash and 2.73 million in debt, giving a net cash position of 12.30 million.
Cash & Cash Equivalents | 15.03M |
Total Debt | 2.73M |
Net Cash | 12.30M |
Net Cash Per Share | n/a |
Equity (Book Value) | 21.07M |
Book Value Per Share | 1.43 |
Working Capital | 9.75M |
Cash Flow
In the last 12 months, operating cash flow was -15.19 million and capital expenditures -665,381, giving a free cash flow of -15.85 million.
Operating Cash Flow | -15.19M |
Capital Expenditures | -665,381 |
Free Cash Flow | -15.85M |
FCF Per Share | n/a |
Margins
Gross margin is 79.94%, with operating and profit margins of -207.04% and -213.98%.
Gross Margin | 79.94% |
Operating Margin | -207.04% |
Pretax Margin | -209.76% |
Profit Margin | -213.98% |
EBITDA Margin | -198.51% |
EBIT Margin | -207.04% |
FCF Margin | n/a |
Dividends & Yields
Medigene AG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.65% |
Shareholder Yield | -2.65% |
Earnings Yield | -761.14% |
FCF Yield | -706.73% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Medigene AG has an Altman Z-Score of -22.4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -22.4 |
Piotroski F-Score | n/a |